
Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
A new case report was published in Oncoscience on September 20, 2023, titled, "Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma."
Jan 15, 2024
0
0